Page last updated: 2024-11-04

sumatriptan and Sulfhemoglobinemia

sumatriptan has been researched along with Sulfhemoglobinemia in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Sulfhemoglobinemia: A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flexman, AM1
Del Vicario, G1
Schwarz, SK1

Other Studies

1 other study available for sumatriptan and Sulfhemoglobinemia

ArticleYear
Dark green blood in the operating theatre.
    Lancet (London, England), 2007, Jun-09, Volume: 369, Issue:9577

    Topics: Adult; Compartment Syndromes; Humans; Male; Migraine Disorders; Sulfhemoglobinemia; Sumatriptan; Vas

2007